Atypicals for Bipolar: And Then There Were Five
The Carlat Psychiatry Report, Volume 3, Number 2, February 2005
Topics: Bipolar Disorder
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
We knew it was about to happen. We just didn’t know it would happen all at once. Between July and September of 2004, Seroquel, Geodon, and Abilify sequentially won approval for the treatment of manic episodes in bipolar disorder.